Compound: danthron
SMILES: O=C1c2c(O)cccc2C(=O)c3c1c(O)ccc3
InChIKey: QBPFLULOKWLNNW-UHFFFAOYSA-N
Synonyms: danthron, 1,8-Dihydroxyanthraquinone, 117-10-2, Dantron, Chrysazin, Dorbane, Istizin, Antrapurol, 1,8-Dihydroxyanthracene-9,10-dione, Diaquone, Altan, Laxanorm, Laxanthreen, Laxipurin, Dionone, Zwitsalax, Danivac, danthrone, 9,10-Anthracenedione, 1,8-dihydroxy-, Dantrone, 1,8-Dihydroxy-9,10-anthraquinone, Dioxyanthrachinonum, Usaf nd-59, 1,8-Dihydroxyanthrachinon, 1,8-Dihydroxy-9,10-anthracenedione, Dantrona, Dantronum, LTAN, 1,8-Dihydroxyanthra-9,10-quinone, 1,4,5,8-Tetroxyantraquinone, Anthraquinone, 1,8-dihydroxy-, Pilules Vinchy N.F., 1,8-dioxyanthraquinone, DTXSID9020328, NSC7210, Z4XE6IBF3V, NSC-38626, NSC-646568, NSC646568, DTXCID10328, CHEBI:3682, NSC38626, RefChem:585175, A06AB03, 204-173-5, Duolax, Laxipur, Chrysazine, Prugol, Roydan, Dorbanex, Criasazin, 1,8-Dihydroanthraquinone, 1,8-dihydroxy-9,10-dihydroanthracene-9,10-dione, 1,8-dihydroxy-anthraquinone, MFCD00001211, NSC 38626, Dantron [INN], NSC 646568, 1,8-dihydroxy anthraquinone, CHEMBL53418, Pastomin, Bancon, Istan, component of Doxan, Neokutin S, component of Modane, Scatron D, Dantron (INN), component of Doxidan, component of Dorbantyl, NCGC00091367-01, NCGC00091367-05, 9, 1,8-dihydroxy-, Anthraquinone,8-dihydroxy-, Dantrone [INN-French], Dantronum [INN-Latin], Dantrona [INN-Spanish], WLN: L C666 BV IVJ DQ NQ, 1,8-Dihydroxyanthrachinon [Czech], Danthron [USP], CAS-117-10-2, CCRIS 3529, Dithranol EP Impurity B, Dantron Impurity Standard, EINECS 204-173-5, UNII-Z4XE6IBF3V, Istizine, Laxapur, AI3-38117, Chrysazin;, Danthron;, Danivac;, Istizin;, HSDB 7764, 3nsq, Danthron, BAN, Dantron, INN, Danthron (Standard), Dorbanex (Salt/Mix), Dorbantyl (Salt/Mix), Spectrum_001750, dihyanthraquin_P41_LT, DANTHRON [HSDB], DANTRON [IARC], DANTHRON [MI], DANTHRON [VANDF], 18-Dihydroxyanthraquinone, DANTRON [MART.], Spectrum2_000603, Spectrum3_000650, Spectrum4_001682, Spectrum5_000324, dihyanthraquin_P21/n_LT, DANTRON [WHO-DD], NCIMech_000114, 1,8-Dihydroxyanthracene-9,10-dione (Danthron), dihyanthraquin_P41212_RT, SCHEMBL83688, BSPBio_002259, KBioGR_001944, KBioSS_002230, SPECTRUM211468, 140861-59-2, MLS000069608, Pilules Vinchy N.F. (TN), DivK1c_000284, SPBio_000506, 1,8-DHAQ, MEGxp0_001693, orb1310280, orb3139090, SCHEMBL29356886, SCHEMBL30544826, ACon1_000135, BDBM11316, HMS500O06, HY-B0923R, KBio1_000284, KBio2_002230, KBio2_004798, KBio2_007366, KBio3_001479, NINDS_000284, 1,8-Dihydroxyanthraquinone, 96%, HMS2091A09, HMS3715F08, HMS5083P11, Pharmakon1600-00211468, 8,9-dihydroxy-1,10-anthraquinone, HY-B0923, MSK15523, NSC-7210, Tox21_111122, Tox21_200986, BBL013161, CCG-35470, EBC-26278, NSC755828, s4561, SBB057973, STK238373, AKOS001583216, Tox21_111122_1, 1,8-Dihydroxyanthra-9,10-quinone #, 9,10-Antiraquinone, 1,8-dihydroxy-, CS-4392, DB04816, FD22098, HS-1003, NSC-755828, IDI1_000284, NCGC00091367-02, NCGC00091367-03, NCGC00091367-04, NCGC00091367-06, NCGC00091367-07, NCGC00091367-08, NCGC00258539-01, DA-72552, NCI60_041443, SMR000059018, SY011288, DITHRANOL IMPURITY B [EP IMPURITY], SBI-0051330.P003, 1,8-Dihydroxy-9,10-anthracenedione, 9CI, D0563, EU-0099935, NS00015698, ST50330603, D07107, F17670, AB00051961_09, Danthron (1,8-Dihydroxyanthracene-9,10-dione), EN300-1693514, F540930, SR-01000721864, Q5221244, SR-01000721864-2, BRD-K10065684-001-02-5, BRD-K10065684-001-03-3, BRD-K10065684-001-06-6, BRD-K10065684-001-07-4, 1,8-Dihydroxyanthraquinone, Vetec(TM) reagent grade, 96%, CHZ, InChI=1/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16
Theoretical properties:
molecular_formula: C14H8O4
molecular_weight: 240.21 g/mol
exact_mass: 240.04225873 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 2
hydrogen_bond_acceptor_count: 4
rotatable_bond_count: 0
heavy_atom_count: 18
topological_polar_surface_area: 74.6 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
physical_state: Red or red-yellow needles or leaves (from alcohol)
color: Red or red-yellow needles or leaves (from alcohol)
boiling_point: Sublimes (NTP, 1992)
melting_point: 379 °F (NTP, 1992)
solubility: less than 1 mg/mL at 64 °F (NTP, 1992)
Descriptions:
pubchem: Dantron (Chrysazin; 1,8-Dihydroxyanthraquinone) can cause cancer according to The World Health Organization's International Agency for Research on Cancer (IARC).
chebi: A dihydroxyanthraquinone that is anthracene-9,10-dione substituted by hydroxy groups at positions 1 and 8.
chembl: DANTHRON is a small molecule listed in the ChEMBL database and has reached clinical trial phase 4.0.
wikipedia: Dantron (INN), also known as chrysazin or 1,8-dihydroxyanthraquinone, is an orange-colored organic substance. Many structurally-related compounds are known. In terms of its molecular structure, it is related anthraquinone by the replacement of two hydrogen atoms by hydroxyl groups (–OH).  It is used in some countries as a stimulant laxative.  
It should not be confused with ondansetron, an unrelated drug that was marketed in South Africa under the trade name "Dantron".